RESPIRATORY INTRODUCTION OF TISSUE FACTOR PATHWAY INHIBITOR IN INFLAMMATORY CONDITIONS INVOLVING RESPIRATORY TRACT

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to pharmaceutical industry and represents using a human tissue factor pathway inhibitor (TFPI) or its biologically active homolog having a sequence more than 90 per cent identical to TFPI as a single active ingredient for preparing a drug effective for treating or reducing a risk of extravascular fibrin accumulation in the human alveolar or bronchoalveolar spaces by the intra-tracheal, intra-alveolar or intra-bronchial introduction through the respiratory passage.;EFFECT: invention provides the effective inhibition of extravascular fibrin accumulation.;14 cl, 2 ex